Kaiser Permanente’s Ventricular Assist Device program
Channel: Kaiser Permanente
Date: 2018-12-20

Heart failure affects nearly 6 million adults in the U.S., and half die within 5 years of diagnosis. The Ventricular Assist Device (VAD) is a promising treatment. Kaiser Permanente Northwest launched its VAD program to improve outcomes and patient satisfaction with this complex and high-risk therapy.